YAP Therapeutics
Laguna Hills, US · Delaware corporation
Founders & leadership
AW
Andrew WadeNamed on SEC filing
OB
Olav B. BergheimNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$30.1M disclosed across 1 round · 2022
▶$30.1MraisedJan 2022 · 6 investors · BiotechnologyRule 506(b)
▶$30.1MraisedJan 2022 · 6 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Andrew WadeExecutive Officer
- Olav B. BergheimExecutive Officer, Director
- Offering amount
- $30.1M
- Amount sold
- $30.1M
- First sale
- Jan 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has YAP Therapeutics raised?
- YAP Therapeutics has disclosed $30.1M raised across 1 round.
- Where is YAP Therapeutics headquartered?
- YAP Therapeutics is headquartered in Laguna Hills, US.